Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Femasys Inc (FEMY)

Femasys Inc (FEMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Femasys Inc 3950 JOHNS CREEK COURT SUITE 100 SUWANEE GA 30024 USA

www.femasys.com Employees: 34 P: 770-500-3910

Description:

Femasys Inc.is a biomedical company focused on transforming women's healthcare by developing novel solutions as well as providing significant clinical impact to address severely underserved areas. The company's lead product candidates offer FemBloc and FemaSeed. Femasys Inc. is based in ATLANTA.

Key Statistics

Overview:

Market Capitalization, $K 28,014
Enterprise Value, $K 10,674
Shares Outstanding, K 22,233
Annual Sales, $ 1,070 K
Annual Net Income, $ -14,250 K
Last Quarter Sales, $ 220 K
Last Quarter Net Income, $ -4,680 K
EBIT, $ -16,120 K
EBITDA, $ -15,640 K
60-Month Beta -2.83
% of Insider Shareholders 12.32%
% of Institutional Shareholders 65.27%
Float, K 19,494
% Float 87.68%
Short Volume Ratio 0.46

Growth:

1-Year Return -15.47%
3-Year Return -82.62%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 08/08/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -0.83
EPS Growth vs. Prev Qtr -23.53%
EPS Growth vs. Prev Year 4.55%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

FEMY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -119.97%
Return-on-Assets % -76.52%
Profit Margin % -1,331.78%
Debt/Equity 0.43
Price/Sales 27.58
Price/Cash Flow N/A
Price/Book 2.63
Book Value/Share 0.51
Interest Coverage -82.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar